These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20951778)

  • 21. Protective effect of Coenzyme Q(10) against oxidative damage in human lens epithelial cells by novel ocular drug carriers.
    Wang S; Zhang J; Jiang T; Zheng L; Wang Z; Zhang J; Yu P
    Int J Pharm; 2011 Jan; 403(1-2):219-29. PubMed ID: 20971176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes.
    Abdelbary G
    Pharm Dev Technol; 2011 Feb; 16(1):44-56. PubMed ID: 20025433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system.
    Chen H; Pan H; Li P; Wang H; Wang X; Pan W; Yuan Y
    Colloids Surf B Biointerfaces; 2016 Jul; 143():455-462. PubMed ID: 27037783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery.
    Chen-yu G; Chun-fen Y; Qi-lu L; Qi T; Yan-wei X; Wei-na L; Guang-xi Z
    Int J Pharm; 2012 Jul; 430(1-2):292-8. PubMed ID: 22486962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery.
    Shen J; Wang Y; Ping Q; Xiao Y; Huang X
    J Control Release; 2009 Aug; 137(3):217-23. PubMed ID: 19393270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis.
    Das S; Ghosh S; De AK; Bera T
    Int J Biol Macromol; 2017 Sep; 102():996-1008. PubMed ID: 28465178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis.
    Ustündağ-Okur N; Gökçe EH; Bozbıyık Dİ; Eğrilmez S; Ozer O; Ertan G
    Eur J Pharm Sci; 2014 Oct; 63():204-15. PubMed ID: 25111119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
    J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions.
    Zhang W; Li X; Ye T; Chen F; Yu S; Chen J; Yang X; Yang N; Zhang J; Liu J; Pan W; Kong J
    Int J Nanomedicine; 2014; 9():4305-15. PubMed ID: 25246787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Formulation, characterization and in vitro-in vivo evaluation of flurbiprofen-loaded nanostructured lipid carriers for transdermal delivery.
    Kawadkar J; Pathak A; Kishore R; Chauhan MK
    Drug Dev Ind Pharm; 2013 Apr; 39(4):569-78. PubMed ID: 22639934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation, characterization and biocompatibility studies of thermoresponsive eyedrops based on the combination of nanostructured lipid carriers (NLC) and the polymer Pluronic F-127 for controlled delivery of ibuprofen.
    Almeida H; Lobão P; Frigerio C; Fonseca J; Silva R; Sousa Lobo JM; Amaral MH
    Pharm Dev Technol; 2017 May; 22(3):336-349. PubMed ID: 28240141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation, characterization and testing of tetracaine hydrochloride-loaded albumin-chitosan microparticles for ocular drug delivery.
    Addo RT; Siddig A; Siwale R; Patel NJ; Akande J; Uddin AN; D'Souza MJ
    J Microencapsul; 2010; 27(2):95-104. PubMed ID: 20055748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability.
    Han S; Shen JQ; Gan Y; Geng HM; Zhang XX; Zhu CL; Gan L
    Acta Pharmacol Sin; 2010 Aug; 31(8):990-8. PubMed ID: 20686524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of mucoadhesive poly(lactide-co-glycolide) nanoparticles for ocular application.
    Yoncheva K; Vandervoort J; Ludwig A
    Pharm Dev Technol; 2011 Feb; 16(1):29-35. PubMed ID: 20038266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
    Shinde UA; Joshi PN; Jain DD; Singh K
    Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chitosan coated nanostructured lipid carriers (NLCs) for loading Vitamin D: A physical stability study.
    Rabelo RS; Oliveira IF; da Silva VM; Prata AS; Hubinger MD
    Int J Biol Macromol; 2018 Nov; 119():902-912. PubMed ID: 30063935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
    Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges.
    Orlu M; Cevher E; Araman A
    Int J Pharm; 2006 Aug; 318(1-2):103-17. PubMed ID: 16687222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.